Biosensors International Group Ltd operates in the Surgical and medical instruments sector. Biosensors International Group, Ltd. develops, manufactures and commercializes medical devices used in interventional cardiology and critical care procedures. The principal activities of the Company are those of investment holding and licensing of medical technology. It operates in three segments: the interventional cardiology segment, which supplies the Company's drug-eluting stent products, coronary bare-metal stents, accompanying stent delivery balloon catheter systems, angioplasty balloons and catheters; the critical care segment, which supplies catheter systems and related accessories used during surgery and intensive care treatment and monitoring, and the licensing revenue segment, which relates to milestone payments and royalties associated with the licensing of its drug-eluting stent technology. On June 25, 2010, the Company acquired Sparrow from CardioMind Inc. On October 20, 2010, the Company acquired Axxess from Devax, Inc. In our complete report available for purchase the company is compared to: Alphatec Holdings, Inc., Conceptus, Inc. and Cryolife, Inc..